Stocks › LQDA

Liquidia Corp

LQDA·Nasdaq·United States United States·USD
$25.91
-1.73 (-6.26%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
LQDA
Liquidia Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
LQDAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of LQDA by members of U.S. Congress · 0 on record

No congressional trades in LQDA on record.

Whale Activity

Position changes in LQDA reported for 2026-06-30 by 10 tracked institutional filers
Increased: 5Decreased: 1Closed: 1No prior filing: 3
  • Increased5
  • New0
  • Held0
  • Decreased1
  • Closed1
  • No prior filing3
FilerSharesValueChange
BlackRock, Inc.10.8M$860.2Mincreased
FINDELL CAPITAL MANAGEMENT LLC3.5M$279.2M—
VANGUARD CAPITAL MANAGEMENT LLC3.1M$250.3Mincreased
VANGUARD PORTFOLIO MANAGEMENT LLC1.5M$122.2Mincreased
D. E. Shaw & Co., Inc.1.3M$101.1Mincreased
TWO SIGMA INVESTMENTS, LP266.8K$21.3Mdecreased
Seven Fleet Capital Management LP256.6K$20.5M—
RENAISSANCE TECHNOLOGIES LLC232.4K$18.5Mincreased
AWH Capital, L.P.73.0K$5.8M—
Citadel Advisors LLC0$0closed

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by LQDA insiders, by quarter · Form 4
-5.0M-2.5M02.5M5.0M2025 Q1: -87.3K2025 Q12025 Q2: -114.8K2025 Q22025 Q3: -959.1K2025 Q32025 Q4: -198.6K2025 Q42026 Q1: -457.2K2026 Q12026 Q2: -2.5M2026 Q22026 Q3: -722.8K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

686 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
SINGH RAMANDirector · Director Sale −8,468 $66.16 $560K Sep 14, 2026 Form 4 ↗
SINGH RAMANDirector · Director Sale −9,024 $68.62 $619K Sep 11, 2026 Form 4 ↗
Krepp SarahChief Human Resource Officer Sale −274 $67.76 $19K Sep 1, 2026 Form 4 ↗
Adair JasonChief Business Officer Sale −41.8K $69.09 $2.9M Aug 21, 2026 Form 4 ↗
Adair JasonChief Business Officer Sale −31.8K $69.09 $2.2M Aug 21, 2026 Form 4 ↗
Rielly-Gauvin KatherineDirector · Director Sale −18.4K $72.23 $1.3M Aug 20, 2026 Form 4 ↗
Rielly-Gauvin KatherineDirector · Director Sale −36.8K $74.99 $2.8M Aug 19, 2026 Form 4 ↗
Saggar RajeevChief Medical Officer Sale −50.0K $74.06 $3.7M Aug 19, 2026 Form 4 ↗
Saggar RajeevChief Medical Officer Sale −29.5K $76.84 $2.3M Aug 17, 2026 Form 4 ↗
Boyle DanaChief Accounting Officer Sale −1,600 $87.53 $140K Jul 27, 2026 Form 4 ↗
Adair JasonChief Business Officer Sale −688 $87.53 $60K Jul 27, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −96.4K $89.44 $8.6M Jul 23, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −3,600 $90.71 $327K Jul 23, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −48.0K $88.65 $4.3M Jul 22, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −37.4K $87.70 $3.3M Jul 22, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −14.6K $89.24 $1.3M Jul 22, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −74.4K $79.98 $6.0M Jul 21, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −556 $80.66 $45K Jul 21, 2026 Form 4 ↗
Bloch Stephen MDirector · Director Sale −3,596 $79.55 $286K Jul 20, 2026 Form 4 ↗
Krepp SarahChief Human Resource Officer Sale −7,306 $71.52 $523K Jul 13, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding LQDA · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Small-Cap ETF
iShares Trust
4.2M$337.5M0.30%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.3M$180.1M0.01%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
1.8M$144.4M0.17%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
771.4K$64.9M0.19%Jul 31, 2026
FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH
Capitol Series Trust
812.8K$64.8M1.05%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
805.9K$64.3M0.07%Jun 30, 2026
iShares Russell 2000 Growth ETF
iShares Trust
651.5K$51.9M0.34%Jun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF
SPDR SERIES TRUST
643.8K$51.3M0.30%Jun 30, 2026
iShares S&P Small-Cap 600 Growth ETF
iShares Trust
631.3K$50.3M0.61%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.521.7K$41.6M0.28%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list LQDA's shares (CUSIP 53635D202), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • BKB Growth Investments, LLCSCHEDULE 13G/A · passive (13G) · 716.3K shares0.8%
    Aug 14, 2026 · ↗
  • PD Joint Holdings, LLC Series 2016-ASCHEDULE 13G/A · passive (13G) · 198.4K shares0.2%
    Aug 14, 2026 · ↗
  • Paul B ManningSCHEDULE 13G/A · passive (13G) · 4.9M shares6.5%
    Aug 14, 2026 · ↗
  • Farallon Capital F5 Master I, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Farallon Capital (AM) Investors, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Farallon Capital Offshore Investors II, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Four Crossings Institutional Partners V, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Farallon Capital Institutional Partners III, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Farallon Capital Institutional Partners II, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗
  • Farallon Capital Institutional Partners, L.P.SCHEDULE 13G/A · passive (13G) · 0 shares0.0%
    Aug 4, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming Liquidia Corp as client

No lobbying filings found naming Liquidia Corp as the client.

Government Contracts

Federal awards to Liquidia Corp · USAspending

No federal contract awards found for Liquidia Corp.

U.S. Patents

Recent USPTO applications naming Liquidia Corp

No USPTO patent applications found for Liquidia Corp.

Annual Financials

From LQDA's 10-K filings · XBRL

No annual XBRL figures on record for LQDA. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history

No stock splits in LQDA's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 8.01, 9.01Other eventsSep 30, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsSep 3, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsAug 12, 2026
    EDGAR ↗
  • 8-K · Items 5.07, 9.01Shareholder voteJun 17, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsJun 8, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsMay 11, 2026
    EDGAR ↗

About Liquidia Corp

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersMORRISVILLE, NC
IncorporatedDE